ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

Second Amended and Restated Registration Rights Agreement

Simultaneously with the closing of the Transactions, the Company, Old R1 RCM, the Sellers, TCP-ASC ACHI Series LLLP, a Delaware limited liability limited partnership ("TCP-ASC"), IHC Health Services, Inc., a Utah non-profit corporation ("IHC"), and Shared Business Services, LLC, a Delaware limited liability company and a subsidiary of LifePoint Health, Inc., a Delaware corporation ("LifePoint", and together with TCP-ASC, IHC and the Sellers, the "Investors") entered into the Second Amended and Restated Registration Rights Agreement (the "Registration Rights



                                       2

--------------------------------------------------------------------------------

Agreement") pursuant to which the Investors received certain registration rights covering the resale of shares of Company Common Stock owned by the Investors, as well as any shares of Company Common Stock issued by the Company upon the exercise of warrants held by certain of the Investors and any securities issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend, stock split, recapitalization or other distribution with respect to, or in exchange for, or in replacement of, the shares of Company Common Stock referenced above (collectively, the "Registrable Securities").

The Registration Rights Agreement provides that (i) IHC may only make one such demand for registration pursuant to a registration statement on Form S-3, (ii) TCP-ASC may only make five demands for registration (of which no more than three may be on a form other than Form S-3) and no more than three demands during any twelve-month period, and (iii) the Sellers may only make four demands for registration (of which no more than one may be on a form other than Form S-3) and no more than three demands during any twelve-month period. The Registration Rights Agreement also provides that whenever the Company registers shares of Company Common Stock under the Securities Act of 1933, as amended (the "Securities Act") (other than on a Form S-4 or Form S-8, or in connection with any employee benefit or dividend reinvestment plan), then each Investor will have the right as specified therein to register its shares of Company Common Stock as part of that registration. The registration rights under the . . .

ITEM 1.02. TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.

The information set forth in Item 1.01 under the heading "Second Amended and Restated Credit Agreement" is incorporated into this Item 1.02 by reference.

ITEM 2.01. COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

Pursuant to the Transaction Agreement, the Transactions were consummated and became effective on June 21, 2022. As a result of the Transactions, among other things, the Company became the parent of Old R1 RCM. The Transactions and the Transaction Agreement were previously described in the Registration Statement and the Proxy Statement/Prospectus.

Pursuant to the Transaction Agreement, each issued and outstanding share of Old R1 RCM Common Stock as of immediately prior to the Holding Company Reorganization was converted into one share of Company Common Stock. In addition, pursuant to the Transaction Agreement and the Assignments, each outstanding warrant to purchase shares of Old R1 RCM Common Stock was converted into a warrant to purchase shares of Company Common Stock with substantially the same terms and conditions as applied to such warrant prior to the closing date.

Pursuant to the Transaction Agreement, as consideration for the Acquisition, the Sellers received an aggregate of 135,929,742 shares of Company Common Stock, subject to certain adjustments following the closing as set forth in the Transaction Agreement.

In addition, pursuant to the Transaction Agreement, upon consummation of the Holding Company Reorganization, each stock option of Old R1 RCM, each restricted stock unit ("RSU") of Old R1 RCM under any compensation or benefit agreement, plan or arrangement of R1 ceased to represent or relate to a share of Old R1 RCM Common Stock and was converted automatically to represent or relate to a share of Company Common Stock, on substantially the same terms and conditions as were applicable to such stock option or RSU. To accomplish the foregoing, effective as of the initial effective time of the Holding Company Reorganization, Old R1 RCM assigned, and the Company assumed, all of its rights and obligations under the Third Amended and Restated



                                       7

--------------------------------------------------------------------------------

2010 Stock Incentive Plan of Old R1 RCM (as amended or modified from time to time, the "2010 Amended Plan") (including the shares underlying such awards), the award agreements evidencing the grants of such awards and the remaining shares available for issuance under the 2010 Amended Plan.

The shares of Old R1 RCM Common Stock, which trade under the symbol "RCM" on Nasdaq, will be suspended from trading on Nasdaq, prior to the open of trading on June 22, 2022. Shares of Company Common Stock will continue regular-way trading on Nasdaq using Old R1 RCM's trading history under the ticker symbol . . .

ITEM 2.03. CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN


           OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.


The information set forth in the "Explanatory Note" and Item 1.01 under the heading "Second Amended and Restated Credit Agreement" of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

ITEM 3.01. NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR


           STANDARD; TRANSFER OF LISTING.


On June 21, 2022, in connection with the Holding Company Reorganization, Old R1 RCM notified Nasdaq that the Holding Company Reorganization had been completed and requested that trading of shares of Old R1 RCM Common Stock be suspended and that Nasdaq file with the U.S. Securities and Exchange Commission (the "Commission") an application on Form 25 to delist the Old R1 RCM Common Stock from Nasdaq and deregister the shares of Old R1 RCM Common Stock under Section 12(b) of the Exchange Act. Old R1 RCM intends to file a certificate on Form 15 requesting that the shares of Old R1 RCM Common Stock be deregistered under the Exchange Act, and that Old R1 RCM's reporting obligations under Section 15(d) of the Exchange Act be suspended (except to the extent of the succession of the Company to the Exchange Act Section 12(b) registration and reporting obligations of Old R1 RCM as described under the heading, "Successor Issuer," under Item 8.01 below).

The information set forth in Item 8.01 under the heading "Successor Issuer," describing the succession of the Company to Exchange Act Section 12(b) and reporting obligations of Old R1 RCM, is incorporated herein by reference.

ITEM 3.02. UNREGISTERED SALES OF EQUITY SECURITIES.

The information set forth in the "Explanatory Note" and Items 1.01 and 2.01 is hereby incorporated by reference in this Item 3.02. Exemption from registration under the Securities Act of 1933, as amended (the "Securities Act"), for the issuance to Sellers of an aggregate of 135,929,742 shares of the Company Common Stock (subject to certain adjustments following the closing as set forth in the Transaction Agreement) pursuant to the terms of the Transaction Agreement is based on Section 4(a)(2) of the Securities Act.

ITEM 3.03. MATERIAL MODIFICATION OF RIGHTS OF SECURITYHOLDERS.

The information set forth in the "Explanatory Note" and in Items 1.01, 2.01 and 5.03 is hereby incorporated by reference in this Item 3.03.



                                       8

--------------------------------------------------------------------------------

ITEM 5.01. CHANGES IN CONTROL OF REGISTRANT

Prior to the consummation of the Transactions, the Company was a direct wholly owned subsidiary of Old R1 RCM. Pursuant to the Transaction Agreement, all shares of Company Common Stock owned by Old R1 RCM immediately prior to the consummation of the Transactions were cancelled without payment therefor. Following this cancellation and the issuance of shares of Company Common Stock in the Transactions, the shares of Company Common Stock became held solely by former Old R1 RCM stockholders and the Sellers.

The information set forth in the "Explanatory Note" and Items 2.01 and 5.02 of this Current Report on Form 8-K is hereby incorporated by reference in this Item 5.01.

ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;


           APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN
           OFFICERS.


Appointment of Certain Officers of the Company; Election of New Directors of the Company

The directors and executive officers of the Company as of immediately following the consummation of the Holding Company Reorganization are the same as the directors and executive officers of Old R1 RCM as of immediately prior to the consummation of the Holding Company Reorganization. Pursuant to the terms of the Sellers' Investor Rights Agreement, on June 21, 2022, the Board appointed Matthew Holt, Jeremy Delinksy and Bradford Kyle Armbrester (collectively, the "New Directors") to the Board following the consummation of the Transactions, with such appointments to be effective as of June 22, 2022. The New Directors will serve until the Company's 2023 Annual Meeting of Stockholders and thereafter until their respective successor is duly elected and qualified, or until their respective earlier death, resignation or removal. Except for the Sellers' Investor Rights Agreement, the New Directors were not selected pursuant to any arrangement or understanding between them and any other person. In addition, the New Directors are not a party to any transaction, or series of transactions, involving the Company required to be disclosed pursuant to Item 404(a) of Regulation S-K. The Board also determined that the New Directors are "independent" within the meaning of Nasdaq rules.

In addition, following the consummation of the Transactions, the Board appointed Lee Rivas as President of the Company.



The charts below list the Company's directors and executive officers, effective
as of June 22, 2022.

Directors

                                                               Year Term Expires
Name                            Age   Year Became a Director       and Class
Bradford Kyle Armbrester (4)    37             2022                  2023
Jeremy Delinsky (1)             47             2022                  2023
David M. Dill                   54             2021                  2023
Michael C. Feiner (2), (3)      80             2017                  2023
Joseph Flanagan                 51             2016                  2023
John B. Henneman III (1), (4)   60             2016                  2023
Matthew Holt (2), (3)           45             2022                  2023
Neal Moszkowski (3)             56             2016                  2023
Ian Sacks (2), (3), (4)         51             2016                  2023
Agnes Bundy Scanlan (4)         64             2021                  2023
Jill Smith (1), (2)             64             2019                  2023
Anthony J. Speranzo             73             2016                  2023
Anthony R. Tersigni (4)         72             2019                  2023
Albert R. Zimmerli              70             2018                  2023


(1) Member of the Audit Committee.

(2) Member of the Human Capital Committee

(3) Member of the Nominating and Corporate Governance Committee.

(4) Member of the Compliance & Risk Management Committee.




Executive Officers

Name                     Age    Position
Joseph Flanagan           51    Chief Executive Officer
Lee Rivas                 48    President
Rachel Wilson             51    Executive Vice President, Chief Financial Officer
                                and Treasurer
John Sparby               46    Executive Vice President, Chief Solutions and
                                Customer Officer
Gary Long                 52    Executive Vice President and Chief Commercial
                                Officer



                                       9

--------------------------------------------------------------------------------

Biographical information about the Company's directors, other than Messrs. Holt, Delinsky and Armbrester, is included in the Registration Statement under the heading "R1 Board of Directors" and is incorporated by reference herein.

Biographical information about each of Messrs. Holt, Delinsky and Armbrester is set forth below:

Bradford Kyle Armbrester. Mr. Armbrester has served as Chief Executive Officer and a Director of Signify Health since April 2018. Prior to this, Mr. Armbrester was at athenahealth, where he served as Senior Vice President and Chief Product Officer from May 2015 to April 2018, leading the core product and operations division, and Vice President, Strategy & Corporate Development from May 2011 to May 2015, driving corporate development through strategic partnerships and investments. He has been a Director at Medalogix since September 2021. Mr. Armbrester holds an MBA from Harvard Business School and an AB in Government from Harvard University. Mr. Armbrester was selected to serve on our Board of Directors because of his management experience and expertise in the healthcare sector.

Jeremy Delinsky. Mr. Delinsky has served as Chief Operating Officer of Devoted Health since May 2017. Previously, Mr. Delinsky served as Chief Technology . . .

ITEM 5.03. AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL


           YEAR.


At the 2022 Annual Meeting of Old R1 RCM stockholders, Old R1 RCM's stockholders approved an amendment to Old R1 RCM's Restated Certificate of Incorporation (the "Old R1 RCM Charter") to increase the number of authorized shares from 500,000,000 to 750,000,000 (the "Charter Amendment").

The Charter Amendment became effective upon its filing with the Secretary of State of the State of Delaware on June 17, 2022 and is filed as Exhibit 3.1 hereto and incorporated by reference herein.

In connection with the completion of the Holding Company Reorganization, the Company's board of directors adopted an Amended and Restated Certificate of Incorporation of the Company and Amended and Restated Bylaws of the Company.

Upon consummation of the Holding Company Reorganization, the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws of the Company were the same as the certificate of incorporation and bylaws of Old R1 RCM immediately prior to the consummation of the Holding Company Reorganization, including after giving effect to the Charter Amendment.



                                       11

--------------------------------------------------------------------------------

The Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on June 21, 2022 and is filed as Exhibit 3.2 hereto and incorporated by reference herein.

The Amended and Restated Bylaws are filed as Exhibit 3.3 hereto and incorporated by reference herein.

ITEM 7.01. REGULATION FD DISCLOSURE.

On June 21, 2022, the Company issued a press release announcing the closing of the Transactions, the entire text of which is attached as Exhibit 99.2 and is incorporated by reference herein.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(a) Financial statements of the business acquired

In reliance on General Instruction B.3 to Form 8-K, the financial statements of the business acquired have been omitted because the Company previously reported substantially the same information in the Registration Statement.

(b) Pro forma financial information

In reliance on General Instruction B.3 to Form 8-K, the pro forma financial information has been omitted because the Company previously reported substantially the same information in the Registration Statement.



Exhibit
  No.                                    Description

 3.1          Amendment to the Old R1 RCM Charter

 3.2          Amended and Restated Certificate of Incorporation of the Company

 3.3          Amended and Restated Bylaws of the Company

 4.1          Second Amended and Restated Registration Rights Agreement, dated as
            of June 21, 2022, by and among the Company, Old R1 RCM, TCP-ASC ACHI
            Series LLLP, IHC Health Services, Inc., Shared Business Services, LLC
            and the Sellers

 4.2          Amended and Restated Investor Rights Agreement, dated June 21, 2022,
            by and among the Company, Old R1 RCM and TCP-ASC ACHI Series LLLP

 4.3          Investor Rights Agreement, dated June 21, 2022, by and among the
            Company and the Sellers

 4.4          Warrant Assignment and Assumption Agreement, dated June 21, 2022, by
            and between the Company and IHC Health Services, Inc.

 4.5          Warrant, dated January 23, 2018, by and between Old R1 RCM and IHC
            Health Services, Inc. (incorporated by reference to Exhibit 10.2 to
            the Current Report of Old R1 RCM on Form 8-K (file No. 001-34746)
            filed on January 24, 2018)

 4.6          Warrant Assignment and Assumption Agreement, dated June 21, 2022, by
            and between the Company and TCP ASC ACHI Series LLLP

 4.7          Warrant, dated February 16, 2016, by and between Old R1 RCM and
            TCP-ASC ACHI Series LLLP (incorporated by reference to Exhibit 10.3 to
            the Quarterly Report of Old R1 RCM on Form 10-Q for the quarter ended
            March 31, 2016 (File No. 001-34746) filed on May 10, 2016).

10.1          Second Amended and Restated Credit Agreement, dated June 21, 2022,
            by and among Old R1 RCM Inc., as the Initial Borrower), the Company,
            as the Ultimate Borrower, the other Persons party thereto that are
            designated as a "Credit Party", Bank of America, N.A., as Agent for
            the several financial institutions from time to time party thereto and
            the Lenders

10.2          Employment Agreement, dated June 21, 2022, by and between the
            Company and Lee Rivas

10.3          R1 RCM Inc. 2022 Inducement Plan

10.4          Form of Standard PBRSU Award Agreement under R1 RCM Inc. 2022
            Inducement Plan

10.5          Form of Pull-forward PBRSU Award Agreement under R1 RCM Inc. 2022
            Inducement Plan

10.6          Form of RSU Award Agreement under R1 RCM Inc. 2022 Inducement Plan

99.1          R1 RCM Inc. Press Release re Inducement Awards, dated June 21,
            2022

99.2          R1 RCM Inc. Press Release re Closing, dated June 21, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)



                                       12

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses